Search Results

There are 3119 results for: content related to: Impact of ustekinumab on health-related quality of life in Japanese patients with moderate-to-severe plaque psoriasis: Results from a randomized, double-blind, placebo-controlled phase 2 / 3 trial

  1. Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial

    British Journal of Dermatology

    Volume 162, Issue 1, January 2010, Pages: 137–146, M. Lebwohl, K. Papp, C. Han, B. Schenkel, N. Yeilding, Y. Wang and G.G. Krueger

    Version of Record online : 9 NOV 2009, DOI: 10.1111/j.1365-2133.2009.09491.x

  2. Impact of ustekinumab on health-related quality of life and sexual difficulties associated with psoriasis: results from two phase III clinical trials

    Journal of the European Academy of Dermatology and Venereology

    Volume 25, Issue 7, July 2011, Pages: 851–857, L. Guenther, C. Han, P. Szapary, B. Schenkel, Y. Poulin, M. Bourcier, J.P. Ortonne and H.L. Sofen

    Version of Record online : 27 APR 2011, DOI: 10.1111/j.1468-3083.2011.04082.x

  3. Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis

    Clinical and Experimental Dermatology

    Volume 39, Issue 6, August 2014, Pages: 696–707, Y. Meng, L. Dongmei, P. Yanbin, F. Jinju, T. Meile, L. Binzhu, H. Xiao, T. Ping and L. Jianmin

    Version of Record online : 14 JUL 2014, DOI: 10.1111/ced.12390

  4. Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years

    British Journal of Dermatology

    Volume 166, Issue 4, April 2012, Pages: 861–872, A.B. Kimball, K.B. Gordon, S. Fakharzadeh, N. Yeilding, P.O. Szapary, B. Schenkel, C. Guzzo, S. Li and K.A. Papp

    Version of Record online : 27 MAR 2012, DOI: 10.1111/j.1365-2133.2012.10901.x

  5. Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment

    Journal of the European Academy of Dermatology and Venereology

    Volume 26, Issue 11, November 2012, Pages: 1331–1344, T.C. Lucka, D. Pathirana, A. Sammain, F. Bachmann, S. Rosumeck, R. Erdmann, J. Schmitt, H. Orawa, B. Rzany and A. Nast

    Version of Record online : 9 MAR 2012, DOI: 10.1111/j.1468-3083.2012.04492.x

  6. You have free access to this content
    Efficacy and safety of ustekinumab in Japanese patients with moderate-to-severe plaque-type psoriasis: Long-term results from a phase 2/3 clinical trial

    The Journal of Dermatology

    Volume 39, Issue 3, March 2012, Pages: 242–252, Atsuyuki IGARASHI, Takeshi KATO, Mai KATO, Michael SONG, Hidemi NAKAGAWA and THE JAPANESE USTEKINUMAB STUDY GROUP

    Version of Record online : 29 SEP 2011, DOI: 10.1111/j.1346-8138.2011.01347.x

  7. You have full text access to this OnlineOpen article
    Ustekinumab Treatment and Improvement of Physical Function and Health-Related Quality of Life in Patients With Psoriatic Arthritis

    Arthritis Care & Research

    Volume 68, Issue 12, December 2016, Pages: 1812–1822, Proton Rahman, Lluis Puig, Alice B. Gottlieb, Arthur Kavanaugh, Iain B. McInnes, Christopher Ritchlin, Shu Li, Yuhua Wang, Michael Song, Alan Mendelsohn, Chenglong Han and on behalf of the PSUMMIT 1 and 2 Study Groups

    Version of Record online : 21 OCT 2016, DOI: 10.1002/acr.23000

  8. ‘Happy’ drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network

    British Journal of Dermatology

    Volume 171, Issue 5, November 2014, Pages: 1189–1196, J.M.P.A. van den Reek, J. Zweegers, W. Kievit, M.E. Otero, P.P.M. van Lümig, R.J.B. Driessen, P.M. Ossenkoppele, M.D. Njoo, J.M. Mommers, M.I.A. Koetsier, W.P. Arnold, B.A.M. Sybrandy-Fleuren, A.L.A. Kuijpers, M.P.M. Andriessen, P.C.M. van de Kerkhof, M.M.B. Seyger and E.M.G.J. de Jong

    Version of Record online : 3 OCT 2014, DOI: 10.1111/bjd.13087

  9. You have free access to this content
    47th Annual Scientific Meeting

    Australasian Journal of Dermatology

    Volume 55, Issue S1, May 2014, Pages: 1–58,

    Version of Record online : 15 MAY 2014, DOI: 10.1111/ajd.12174

  10. Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasis

    Journal of the European Academy of Dermatology and Venereology

    M. Augustin, C. Blome, C. Paul, L. Puig, T. Luger, J. Lambert, S. Chimenti, G. Girolomoni, K. Kragballe, D. Naessens, P. Bergmans, P. Smirnov, J. Barker and K. Reich

    Version of Record online : 12 AUG 2016, DOI: 10.1111/jdv.13823

  11. Practical experience of ustekinumab in the treatment of psoriasis: experience from a multicentre, retrospective case cohort study across the U.K. and Ireland

    British Journal of Dermatology

    Volume 166, Issue 1, January 2012, Pages: 189–195, P.M. Laws, A.M. Downs, R. Parslew, B. Dever, C.H. Smith, J.N. Barker, B. Moriarty, R. Murphy, B. Kirby, A.D. Burden, S. McBride, A.V. Anstey, S. O’Shea, N. Ralph, C. Buckley, C.E.M. Griffiths and R.B. Warren

    Version of Record online : 27 DEC 2011, DOI: 10.1111/j.1365-2133.2011.10638.x

  12. Clear or almost clear skin improves the quality of life in patients with moderate-to-severe psoriasis: a systematic review and meta-analysis

    Journal of the European Academy of Dermatology and Venereology

    L. Puig, H. Thom, P. Mollon, H. Tian and G.S. Ramakrishna

    Version of Record online : 28 OCT 2016, DOI: 10.1111/jdv.14007

  13. Consensus document on the evaluation and treatment of moderate-to-severe psoriasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology

    Journal of the European Academy of Dermatology and Venereology

    Volume 30, Issue S2, March 2016, Pages: 1–18, E. Daudén, L. Puig, C. Ferrándiz, J.L. Sánchez-Carazo, J.M. Hernanz-Hermosa and on behalf of the Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology

    Version of Record online : 26 JAN 2016, DOI: 10.1111/jdv.13542

  14. Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives

    Annals of the New York Academy of Sciences

    Volume 1222, Issue 1, March 2011, Pages: 30–39, Newman Yeilding, Philippe Szapary, Carrie Brodmerkel, Jacqueline Benson, Michael Plotnick, Honghui Zhou, Kavitha Goyal, Brad Schenkel, Jill Giles-Komar, Mary Ann Mascelli and Cynthia Guzzo

    Version of Record online : 22 MAR 2011, DOI: 10.1111/j.1749-6632.2011.05963.x

  15. One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate-to-severe plaque psoriasis

    British Journal of Dermatology

    Volume 170, Issue 2, February 2014, Pages: 435–444, K. Reich, L. Puig, C. Paul, K. Kragballe, T. Luger, J. Lambert, S. Chimenti, G. Girolomoni, J.-F. Nicolas, E. Rizova, M. Brunori, S. Mistry, P. Bergmans, J. Barker and on behalf of the TRANSIT Investigators

    Version of Record online : 18 FEB 2014, DOI: 10.1111/bjd.12643

  16. S3 – Guidelines on the treatment of psoriasis vulgaris (English version). Update

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 10, Issue s2, March 2012, Pages: S1–s95, Alexander Nast, Wolf-Henning Boehncke, Ulrich Mrowietz, Hans-Michael Ockenfels, Sandra Philipp, Kristian Reich, Thomas Rosenbach, Adel Sammain, Martin Schlaeger, Michael Sebastian, Wolfram Sterry, Volker Streit, Matthias Augustin, Ricardo Erdmann, Joachim Klaus, Joachim Koza, Siegrid Muller, Hans-Dieter Orzechowski, Stefanie Rosumeck, Gerhard Schmid-Ott, Tobias Weberschock and Berthold Rzany

    Version of Record online : 5 MAR 2012, DOI: 10.1111/j.1610-0387.2012.07919.x

  17. Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT)

    British Journal of Dermatology

    Volume 170, Issue 2, February 2014, Pages: 425–434, C. Paul, L. Puig, K. Kragballe, T. Luger, J. Lambert, S. Chimenti, G. Girolomoni, J.-F. Nicolas, E. Rizova, F. Lavie, S. Mistry, P. Bergmans, J. Barker and K. Reich, on behalf of the TRANSIT Investigators

    Version of Record online : 18 FEB 2014, DOI: 10.1111/bjd.12646

  18. Efficacy of ustekinumab in refractory palmoplantar pustular psoriasis

    British Journal of Dermatology

    Volume 168, Issue 4, April 2013, Pages: 820–824, C. Morales-Múnera, E. Vilarrasa and L. Puig

    Version of Record online : 25 MAR 2013, DOI: 10.1111/bjd.12150

  19. You have free access to this content
    Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study

    Journal of the European Academy of Dermatology and Venereology

    Volume 27, Issue 12, December 2013, Pages: 1535–1545, A.B. Kimball, K.A. Papp, Y. Wasfi, D. Chan, R. Bissonnette, H. Sofen, N. Yeilding, S. Li, P. Szapary, K.B. Gordon and on behalf of the PHOENIX 1 investigators

    Version of Record online : 20 DEC 2012, DOI: 10.1111/jdv.12046

  20. Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris

    British Journal of Dermatology

    Volume 172, Issue 1, January 2015, Pages: 244–252, R. Gniadecki, B. Bang, L.E. Bryld, L. Iversen, S. Lasthein and L. Skov

    Version of Record online : 30 NOV 2014, DOI: 10.1111/bjd.13343